-
A randomized clinical trial involving over 3,000 elderly people in the US found that the popular herbal supplement Gingko biloba fared no better than placebo at preventing dementia or Alzheimer's disease. The research was the work of the Ginkgo Evaluation of Memory (GEM) Study Investigators who are based at centers ...
-
To bring awareness about a devastating disease that affects thousands of Kentuckians and their families, Gov. Steve Beshear has proclaimed November Alzheimer's Disease Awareness Month in Kentucky. Alzheimer's disease (AD) is the most common form of the brain diseases known as dementia....
-
Three fifths of adults would like to see hospitals and healthcare providers penalised for failing to help older people in pain according to a report released recently. The report also highlighted a lack of confidence in health professionals that can alleviate pain and a dismissal of pain in older people. ...
-
Dementia is caused by diseases of the brain and robs people of their lives. It is not a natural part of ageing, but age is the biggest risk factor. This small study may be a stepping-stone to further research that helps us understand why some people retain good cognitive function ...
-
Scientists at The Feinstein Institute for Medical Research have figured out why a substance in red grapes and red wine lowers amyloid beta levels that accumulate in the brains of Alzheimer's patients. Medicines targeting amyloid beta that make up the clumps in the hallmark plaques are now in many phases ...
-
Maybe you have an 85-year-old grandfather who still whips through the newspaper crossword puzzle every morning or a 94-year-old aunt who never forgets a name or a face. They don't seem to suffer the ravages of memory that beset most people as they age. Researchers at Northwestern University's Feinberg School ...
-
A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans. The new research is published in the November 18, 2008, print issue of Neurology®, the medical journal of the American Academy of Neurology. Growth ...
-
Scientists have unraveled in unprecedented detail the cascade of events that go wrong in brain cells affected by HIV, a virus whose assault on the nervous system continues unabated despite antiviral medications that can keep the virus at bay for years in the rest of the body. The new research ...
-
Researchers at Southern Methodist University (SMU) and The University of Texas at Dallas (UTD) have identified a group of chemical compounds that slow the degeneration of neurons, a condition behind old-age diseases like Alzheimer's, Parkinson's and amyotrophic lateral sclerosis (ALS). Their findings are featured in the November 2008 edition of ...
-
University of Central Florida students are helping people with Alzheimer's disease and related disorders through an innovative program that blends traditional therapy along with games such as the Wii and yoga. Media are invited to attend a session from 10 a.m. to noon on Friday, Nov. 14, or Friday, Nov. ...
-
Walter J. Lukiw, PhD, Associate Professor of Neuroscience and Ophthalmology at LSU Health Sciences Center New Orleans, is the lead author of a paper identifying, for the first time, a specific function of a fragment of ribonucleic acid (RNA), once thought to be no more than a byproduct, in regulating ...
-
The only known genetic risk factor for Alzheimer's disease slows down the brain's ability to export a toxic protein known as amyloid-beta that is central to the damage the disease causes, scientists have found. The research, published Nov. 13 by the Journal of Clinical Investigation, provides new clues into the ...
-
Saint Louis University researchers have identified a novel way of getting a potential treatment for Alzheimer's disease and stroke into the brain where it can do its work. "We found a unique approach for delivering drugs to the brain," says William A. Banks, M.D., professor of geriatrics and pharmacological and ...
-
For the first time researchers have shown that a commonly used anesthetic can produce changes associated with Alzheimer's disease in the brains of living mammals, confirming previous laboratory studies. In their Annals of Neurology report, which has received early online release, a team of Massachusetts General Hospital (MGH) investigators shows ...
-
Linguistic techniques could be useful for assessing communications problems in people with dementia. Examining a person's diary could give valuable insight into how a person's communication skills have changed over time and help with diagnosis. Harold Wilson's speeches may be part of political history, but they could form an important ...
-
Alzheimer's Society has welcomed draft regulations for direct payments today as the Department of Health consultation closes. The draft regulations extend direct payments to people who lack capacity and remove the blanket exclusion that currently applies to people who are subject to various provisions of mental health legislation. Extending direct ...
-
Researchers from the Peninsula Medical School, Plymouth Hospitals NHS Trust and the University of Plymouth, have received a grant funding of £2million over the next five years from the National Institute for Health Research (NIHR) to investigate new ways of developing clinical trials for the treatment of Alzheimer's disease and ...
-
In the largest study of its kind, Pittsburgh Compound B, an imaging agent that could facilitate the early diagnosis of Alzheimer's disease, has been used to identify amyloid deposition in the brains of clinically older adults. The findings, published in this month's issue of the Archives of Neurology, could not ...
-
In the largest study of its kind, Pittsburgh Compound B, an imaging agent that could facilitate the early diagnosis of Alzheimer's disease, has been used to identify amyloid deposition in the brains of clinically older adults. The findings, published in this month's issue of the Archives of Neurology, could not ...
-
Even with evidence of brain plaques associated with Alzheimer's disease, highly educated individuals manage to score higher on cognitive tests. Results from this study are published in the November issue of Archives of Neurology. Currently there exists a popular notion - the "cognitive reserve" hypothesis - that people with greater ...
